BioSpace News Archive

Policy

New York-based food processors agree to stop food preparation operations due to food safety violations

Two New York-based food processing companies have agreed to stop preparing food products

July 17, 2018
·
4 min read
Deals

Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket, A Provider of Software and Technology-enabled Solutions Utilized in Clinical Trials

Combined organization will bring together complementary strengths with a shared focus on accelerated customer value through patient-centric clinical technology solutions

July 17, 2018
·
5 min read
Business

Exelixis to Release Second Quarter 2018 Financial Results on Wednesday, August 1, 2018

Conference Call and Webcast to Follow at 5:00 p.m. EDT/ 2:00 p.m. PDT

July 17, 2018
·
2 min read
Biotech Beach

American Funds Launches ABLEAmerica®, a Tax-Advantaged Savings Plan for Disability Expenses

First advisor-sold ABLE plan helps individuals with disabilities save for a brighter future

July 17, 2018
·
4 min read
Business

White Marsh Plaza Welcomes For Eyes Optical Experts

One-Stop Solution for Quality, Affordable Vision Care Opens in Nottingham

July 17, 2018
·
3 min read
FDA

Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S FDA has approved SYMTUZA™, the first and only complete, darunavir-based single-tablet regimen (STR) for the treatment of human immunodeficiency virus type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.

July 17, 2018
·
13 min read
Polares Medical Closes a $25M Financing to Enter Clinical Validation

Polares Medical SA announced the closing of a $25 million financing led by Decheng Capital (Menlo Park and Shanghai) together with Endeavour Vision (Geneva), IDO Investments (Muscat), Earlybird Venture Capital (Berlin) and Wellington Partners (Munich).

July 17, 2018
·
1 min read
Business

Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations

Moriarty brings 18 years of clinical industry experience to Spruce to advance SPR001, the company’s lead program for congenital adrenal hyperplasia (CAH), through Phase 2 clinical trials and expand into additional indications

July 17, 2018
·
3 min read
Business

Caliber Imaging & Diagnostics, Inc. Names Karen Howe as Chief Financial Officer

Ms. Howe joins Caliber I.D. with over 14-years of extensive financial experience in high-tech, manufacturing and financial services.

July 17, 2018
·
2 min read
Drug Development

Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole

Single dose of Pulmazole safe and well tolerated in subjects with asthma

July 17, 2018
·
7 min read